STOCK TITAN

Naturl Alt Intl Stock Price, News & Analysis

NAII Nasdaq

Welcome to our dedicated page for Naturl Alt Intl news (Ticker: NAII), a resource for investors and traders seeking the latest updates and insights on Naturl Alt Intl stock.

Naturl Alt Intl (NAII) delivers science-backed nutritional solutions through advanced manufacturing and strategic partnerships. This news hub provides investors and industry professionals with essential updates on the company's operational milestones, product innovations, and market positioning.

Access authoritative reporting on NAII's financial disclosures, regulatory achievements, and clinical research collaborations. Our curated collection includes earnings reports, manufacturing capacity expansions, patent filings, and quality assurance certifications - all critical for evaluating the company's industry leadership.

Key updates cover formulation advancements, production facility upgrades, and partnership agreements with healthcare organizations. Track NAII's progress in developing condition-specific supplements while maintaining compliance with global regulatory standards.

Bookmark this page for streamlined access to NAII's latest developments in private-label manufacturing and nutritional science. Check regularly for verified updates that matter to stakeholders in the nutraceuticals sector.

Rhea-AI Summary

Natural Alternatives International (NAII) announced its fiscal 2024 Q3 results, revealing a net loss of $1.6 million, or ($0.27) per diluted share, on net sales of $25.1 million. This compares to a $2.4 million net loss in Q3 of the prior year. Q3 net sales fell by 23%, driven by a 26% decrease in private-label contract manufacturing sales. However, CarnoSyn® beta-alanine revenue rose 13% to $2.7 million. For the nine months ending March 31, 2024, NAII reported a net loss of $5.3 million on net sales of $84.3 million, a 29% decrease year-over-year. Cash reserves stood at $12.4 million, with zero outstanding on their credit facility. The company expects to report a net loss for Q4 and fiscal 2024 due to ongoing market adjustments but forecasts future sales growth and a return to profitability with the reopening of their Carlsbad facility in May 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.46%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.55%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.22%
Tags
partnership
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.34%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.89%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.2%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-21.58%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.72%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.66%
Tags
none

FAQ

What is the current stock price of Naturl Alt Intl (NAII)?

The current stock price of Naturl Alt Intl (NAII) is $2.69 as of October 16, 2025.

What is the market cap of Naturl Alt Intl (NAII)?

The market cap of Naturl Alt Intl (NAII) is approximately 17.0M.
Naturl Alt Intl

Nasdaq:NAII

NAII Rankings

NAII Stock Data

16.99M
4.86M
21.59%
33.41%
0.24%
Packaged Foods
Medicinal Chemicals & Botanical Products
Link
United States
CARLSBAD